Carbapenem-resistant gram-negative bacteria in Germany: incidence and distribution among specific infections and mortality: an epidemiological analysis using real-world data
| العنوان: | Carbapenem-resistant gram-negative bacteria in Germany: incidence and distribution among specific infections and mortality: an epidemiological analysis using real-world data |
|---|---|
| المؤلفون: | Michael H. Wilke, Birgit Preisendörfer, Anna Seiffert, Maria Kleppisch, Caroline Schweizer, Stephan Rauchensteiner |
| المصدر: | Infection. 50:1535-1542 |
| بيانات النشر: | Springer Science and Business Media LLC, 2022. |
| سنة النشر: | 2022 |
| مصطلحات موضوعية: | Microbiology (medical), Drug Combinations, Infectious Diseases, Carbapenems, Incidence, Gram-Negative Bacteria, Urinary Tract Infections, Humans, General Medicine, Ceftazidime, Anti-Bacterial Agents |
| الوصف: | Purpose Infections with carbapenem-resistant gram-negative bacteria (in Germany classified as 4MRGN) are a growing threat in clinical care. This study was undertaken to understand the overall burden of 4MRGN infections in Germany in the context of a Health Technology Appraisal (HTA) for Ceftazidime/Avibactam (CAZ/AVI). Besides, the incidences mortality was an endpoint of interest. Methods To assess infections with carbapenem-resistant gram-negative bacteria and related mortality, three different data sources have been used. From the German statistics office (DESTATIS) data have been retrieved to obtain the overall frequency these pathogens. Via two other databases, the German analysis database (DADB) and a Benchmarking of > 200 hospitals in a representative sample (BM-DB), the distribution of the infections and the mortality have been analyzed. Results DESTATIS data showed a total of 11,863 carbapenem-resistant gram-negative bacteria codings, of which 10,348 represent infections and 1515 carriers. The most frequent infections were complicated urinary tract infections (cUTI) (n = 2,337), followed by pneumonia (n = 1006) and intra-abdominal infections (n = 730). A considerable amount of patients had multiple infections in one hospital episode (n = 1258). In-hospital mortality was 18.6% in DADB and 14.3% in the BM-DB population, respectively. In cases with additional bloodstream infections, DADB mortality was correspondingly higher at 33.0%. DADB data showed an incremental mortality increase of 5.7% after 30 days and 10.0% after 90 days resulting in a cumulative 90 day mortality of 34.3%. Conclusions Infections with carbapenem-resistant gram-negative bacteria are still rare (6.8–12.4 per 100,000) but show a significant increase in mortality compared to infections with more sensitive pathogens. Using different data sources allowed obtaining a realistic picture. |
| تدمد: | 1439-0973 0300-8126 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::075c58aebba1afacaa0d5b9809c877fd https://doi.org/10.1007/s15010-022-01843-6 |
| حقوق: | OPEN |
| رقم الأكسشن: | edsair.doi.dedup.....075c58aebba1afacaa0d5b9809c877fd |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 14390973 03008126 |
|---|